Sernova (STU:PSH) Price-to-Tangible-Book : (As of Dec. 13, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Sernova Price-to-Tangible-Book?

As of today (2024-12-13), Sernova's share price is €0.1482. Sernova's Tangible Book per Share of Jul. 2024 for the quarter that ended in Jul. 2024 was €-0.03. Hence, Sernova's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Sernova's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Sernova's highest Price to Tangible Book Ratio was 98.33. The lowest was 5.16. And the median was 11.36.

STU:PSH's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.82
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Sernova's share price is €0.1482. Sernova's Book Value per Sharefor the quarter that ended in Jul. 2024 was €-0.03. Hence, Sernova's P/B Ratio of today is .

Sernova Price-to-Tangible-Book Historical Data

The historical data trend for Sernova's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Price-to-Tangible-Book Chart

Sernova Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Price-to-Tangible-Book

Get a 7-Day Free Trial

7.65

17.00

11.92

4.95

19.14

Sernova Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Price-to-Tangible-Book	Get a 7-Day Free Trial															11.73	19.14	52.70	-	-

Competitive Comparison of Sernova's Price-to-Tangible-Book

For the Biotechnology subindustry, Sernova's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Sernova's Price-to-Tangible-Book falls into.

Sernova Price-to-Tangible-Book Calculation

Sernova's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jul. 2024 )
	=	0.1482	/	-0.028
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Sernova Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Sernova's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (STU:PSH) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH:Germany PSH:Germany SVA:Canada

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is is a scalable, implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.